Skip to content

OS Therapies OSTX Preferred stock issuance

Preferred stock issuance at other companies

Solidion Technology, Inc. logo
Solidion Technology, Inc.STI
$241.55K
OS Therapies logo
OS TherapiesOSTX
$263.25K
Apollo Global Management logo
Apollo Global ManagementAPO
28.7M0.0%
Our Bond, Inc.
 logo
Our Bond, Inc. OBAI
$2K-33.3%
Kimberly-Clark logo
Kimberly-ClarkKMB
$0
Henry (Jack) & Associates logo
Henry (Jack) & AssociatesJKHY
$0

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's preferred stock issuance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's preferred stock issuance?
OS Therapies (OSTX) reported preferred stock issuance of $263.25K in Q1 2025.
What does preferred stock issuance mean?
The estimated fair value of warrants issued in connection with specific debt or financing facilities. This metric helps investors quantify the additional cost of capital beyond stated interest rates, reflecting the equity component of complex financing arrangements.